![](/img/cover-not-exists.png)
AOS13 Denosumab versus zoledronic acid for the prevention of skeletal-related events in patients with bone metastases secondary to solid tumours: An integrated analysis of three phase 3 studies
A.T. Stopeck, G. Richardson, S. Siena, A. Lipton, J. Brown, K. Fizazi, D. Henry, F. Saad, C. Ke, A. BraunVolume:
48
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.ejca.2012.02.030
File:
PDF, 41 KB
english, 2012